Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-14

Clinical Trial Update: Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a pediatric epilepsy study focusing on pharmacokinetics, pharmacodynamics, and pharmacogenetics in Childhood Absence Epilepsy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Childhood Absence Epilepsy, Petit Mal Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2020-10-14